Avertissement: Ce site agrège des données publiques officielles provenant de la FDA, ClinicalTrials.gov, PubMed et SEC EDGAR à titre de référence générale uniquement. Il ne constitue pas un avis médical, un diagnostic, une recommandation de traitement ni un conseil en investissement.

PubMed

Regulatory Aspects of Artificial Intelligence and Machine Learning.

PMID : 39260776 ·

L, i, r, o, n, , P, a, n, t, a, n, o, w, i, t, z, ;, , M, a, t, t, h, e, w, , H, a, n, n, a, ;, , J, o, s, h, u, a, , P, a, n, t, a, n, o, w, i, t, z, ;, , J, o, e, , L, e, n, n, e, r, z, ;, , W, a, l, t, e, r, , H, , H, e, n, r, i, c, k, s, ;, , P, e, t, e, r, , S, h, e, n, ;, , B, r, u, c, e, , Q, u, i, n, n, ;, , S, h, a, n, n, o, n, , B, e, n, n, e, t, ;, , H, o, o, m, a, n, , H, , R, a, s, h, i, d, i

RevueModern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc
Année
PMID39260776

Résumé

In the realm of health care, numerous generative and nongenerative artificial intelligence and machine learning (AI-ML) tools have been developed and deployed. Simultaneously, manufacturers of medical devices are leveraging AI-ML. However, the adoption of AI in health care raises several concerns, including safety, security, ethical biases, accountability, trust, economic impact, and environmental effects. Effective regulation can mitigate some of these risks, promote fairness, establish standar

Source officielle

Voir sur PubMed →

Données issues de PubMed / NCBI. Pour le texte intégral et les informations les plus récentes, consultez toujours la notice officielle.

↑